MiMedx filed with FDA to initiate an Investigational New Drug Phase III Achilles Tendonitis clinical study comparing AmnioFix® Injectable to saline placebo.
The prospective, double blinded, randomized controlled trial will enroll ~160 subjects with moderate to severe pain that failed conservative treatment for at least one month.
The announcement closely follows news of a Phase III study to evaluate AmnioFix Injectable vs. placebo in the treatment of Plantar Fasciitis.
MiMedx filed with FDA to initiate an Investigational New Drug Phase III Achilles Tendonitis clinical study comparing AmnioFix® Injectable to saline placebo.
The prospective, double blinded, randomized controlled trial will enroll 60 subjects with moderate to severe pain that failed conservative treatment for at least one month.
The...
MiMedx filed with FDA to initiate an Investigational New Drug Phase III Achilles Tendonitis clinical study comparing AmnioFix® Injectable to saline placebo.
The prospective, double blinded, randomized controlled trial will enroll ~160 subjects with moderate to severe pain that failed conservative treatment for at least one month.
The announcement closely follows news of a Phase III study to evaluate AmnioFix Injectable vs. placebo in the treatment of Plantar Fasciitis.
Copy to clipboard 
